Revival Research Institute, LLC
Dearborn, Michigan 48126
6 studies enrolling now · 11 studies all time
What they study most
Alzheimer's Disease, Atherosclerotic Cardiovascular Disease (ASCVD), COPD, COVID-19 SARS-CoV-2 Infection, Cardiac Disease, Chronic Kidney Disease (CKD), Difficult to Control Hypertension, Elevated Lp(a), Moderate to Severe Chronic Obstructive Pulmonary Disease, Smoking, Type 2 Diabetes
Studies at this site
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse — Recruiting now
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease — Recruiting now
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — Recruiting now
- A Study to Evaluate Solrikitug in Participants With COPD (ZION) — Recruiting now
- To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension — Recruiting now
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
- A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling
- A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin — Completed
- Kosmos Trio and Ejection Fraction Pivotal Study — Completed